Medtech financings for July (to date) stand at nearly $375 million

Financings at medical technology companies for July to date stand at $373.7 million.  Companies included are those in MedMarket Diligence’s area of focus:  medical device and complementary or directly competing companies.

Below are the individual companies included, ranked by the amount financed at each. 

Financing amount

Company (technology focus)


Small Bone Innovations, Inc., raises record $108 million in Series D financing (technologies and treatments for small bones and joints)


ConforMIS Inc. has raised $50 million (custom knee implants and instrumentation)


Oraya Therapeutics has raised $42 million in Series C financing (radiosurgical treatments for eye diseases)


Paradigm Spine has closed on $21.5 million in debt and equity financing (non-fusion spinal implants)


Symetis SA raises $21.2 million to fund clinical trials (percutaneous valve replacement system)


Relievant Medsystems Announces Completion of $20 Million Financing (nerve ablation for treatment of low back pain)


Novasys Medical has received $18.95 million in the second tranche of its fourth round of funding (treatment of stress urinary incontinence)


Lumenis Ltd has received a $15 million equity financing (RF and light-based ablation devices)


BeneChill has raised $13.5 million in Series C funding (therapeutic hypothermia device for cardiac arrest, stroke, and head injury)


Cardiorobotics has raised $11.6 million in an undisclosed financing round (remotely operated minimally invasive probe used in heart and other surgery)


NICO Corp. has raised $10 million in a Series C financing round (minimally invasive removal of tumors from brain and central nervous system tissue)


Chase Medical, Inc., has received $8.1 million of a planned $9.1 million financing round (device used during treatment of congestive heart failure)


Vidacare Corp. has raised $7.6 million in a Series D1 financing round (intraosseous drug and fluid delivery)


EndoGastric Solutions has raised $7.5 million (endoscopic treatment of gastroesophageal reflux and obesity)


Augmenix, Inc., has raised $4.7 million out of a potential $7.5 million undisclosed equity financing round (hydrogel spacers for use in radiation oncology)


SpineGuard S.A. raises $4 million, completing a $15 million first round funding that began with an $11 million round in April (pedicle screw replacement in spine surgery)


SafeStitch Medical, Inc., has entered into two stock purchase agreements with private investors worth $9 million (endoscopic surgical devices)


NeoChord, Inc., has raised $2.8 million in a Series A financing (device for repair of mitral valve regurgitation)


TransMedics, Inc., has raised $2.5 million in a debt offering (organ transplant support technologies)


TriVirix International has raised $750K out of a planned $1.4 million Series C round (contract device manufacturer)




Leave a Reply